238 related articles for article (PubMed ID: 3927973)
21. Pepstatin-derived inhibitors of aspartic proteinases. A close look at an apparent transition-state analogue inhibitor.
Rich DH
J Med Chem; 1985 Mar; 28(3):263-73. PubMed ID: 3882966
[No Abstract] [Full Text] [Related]
22. Pepstatin analogues as novel renin inhibitors.
Guégan R; Diaz J; Cazaubon C; Beaumont M; Carlet C; Clément J; Demarne H; Mellet M; Richaud JP; Segondy D
J Med Chem; 1986 Jul; 29(7):1152-9. PubMed ID: 3543358
[TBL] [Abstract][Full Text] [Related]
23. Replacement of isobutyl by trifluoromethyl in pepstatin A selectively affects inhibition of aspartic proteinases.
Binkert C; Frigerio M; Jones A; Meyer S; Pesenti C; Prade L; Viani F; Zanda M
Chembiochem; 2006 Jan; 7(1):181-6. PubMed ID: 16307463
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of dideoxy-pepstatin. Mechanism of inhibition of porcine pepsin.
Rich DH; Sun E; Singh J
Biochem Biophys Res Commun; 1977 Jan; 74(2):762-7. PubMed ID: 319803
[No Abstract] [Full Text] [Related]
25. Inhibition of 1,4-beta-D-xylan xylanohydrolase by the specific aspartic protease inhibitor pepstatin: probing the two-step inhibition mechanism.
Vathipadiekal V; Rao M
J Biol Chem; 2004 Nov; 279(45):47024-33. PubMed ID: 15317808
[TBL] [Abstract][Full Text] [Related]
26. Structure-Activity Relationships of JMV4463, a Vectorized Cathepsin D Inhibitor with Antiproliferative Properties: The Unique Role of the AMPA-Based Vector.
Vezenkov LL; Sanchez CA; Bellet V; Martin V; Maynadier M; Bettache N; Lisowski V; Martinez J; Garcia M; Amblard M; Hernandez JF
ChemMedChem; 2016 Feb; 11(3):302-8. PubMed ID: 26639308
[TBL] [Abstract][Full Text] [Related]
27. Determination of pepstatin-sensitive carboxyl proteases by using pepstatinyldansyldiaminopropane (dansyl-pepstatin) as an active site titrant.
Yonezawa H; Uchikoba T; Kaneda M
J Biochem; 1997 Aug; 122(2):294-9. PubMed ID: 9378705
[TBL] [Abstract][Full Text] [Related]
28. New renin inhibitors containing novel analogues of statine.
Jones DM; Sueiras-Diaz J; Szelke M; Leckie BJ; Beattie SR; Morton J; Neidle S; Kuroda R
J Pept Res; 1997 Aug; 50(2):109-21. PubMed ID: 9273895
[TBL] [Abstract][Full Text] [Related]
29. New renin inhibitors homologous with pepstatin.
Eid M; Evin G; Castro B; Menard J; Corvol P
Biochem J; 1981 Aug; 197(2):465-71. PubMed ID: 7034718
[TBL] [Abstract][Full Text] [Related]
30. The effects of lactoyl-pepstatin and the pepsin inhibitor peptide on pig cathepsin D.
Kay J; Afting EG; Aoyagi T; Dunn BM
Biochem J; 1982 Jun; 203(3):795-7. PubMed ID: 7115318
[TBL] [Abstract][Full Text] [Related]
31. Accumulation of pepstatin in cultured endothelial cells and its effect on endothelial processing.
Shields PP; Gonzales TA; Charles D; Gilligan JP; Stern W
Biochem Biophys Res Commun; 1991 Jun; 177(3):1006-12. PubMed ID: 2059194
[TBL] [Abstract][Full Text] [Related]
32. Analysis of structure-activity relationships in renin substrate analogue inhibitory peptides.
Hui KY; Carlson WD; Bernatowicz MS; Haber E
J Med Chem; 1987 Aug; 30(8):1287-95. PubMed ID: 3302256
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes.
Rich DH; Moon BJ; Harbeson S
J Med Chem; 1984 Apr; 27(4):417-22. PubMed ID: 6142952
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of cathepsin D by tripeptides containing statine analogs.
Bessodes M; Antonakis K; Herscovici J; Garcia M; Rochefort H; Capony F; Lelièvre Y; Scherman D
Biochem Pharmacol; 1999 Jul; 58(2):329-33. PubMed ID: 10423175
[TBL] [Abstract][Full Text] [Related]
35. Structural and mechanistic insight into the inhibition of aspartic proteases by a slow-tight binding inhibitor from an extremophilic Bacillus sp.: correlation of the kinetic parameters with the inhibitor induced conformational changes.
Dash C; Phadtare S; Deshpande V; Rao M
Biochemistry; 2001 Sep; 40(38):11525-32. PubMed ID: 11560501
[TBL] [Abstract][Full Text] [Related]
36. Miraziridine A: natures blueprint towards protease class-spanning inhibitors.
Schaschke N
Bioorg Med Chem Lett; 2004 Feb; 14(4):855-7. PubMed ID: 15012981
[TBL] [Abstract][Full Text] [Related]
37. Structure of the Rhizomucor miehei aspartic proteinase complexed with the inhibitor pepstatin A at 2.7 A resolution.
Yang J; Quail JW
Acta Crystallogr D Biol Crystallogr; 1999 Mar; 55(Pt 3):625-30. PubMed ID: 10089458
[TBL] [Abstract][Full Text] [Related]
38. Studies of HIV-1 protease inhibitors. I. Incorporation of a reduced peptide, simple aminoalcohol, and statine analog at the scissile site of substrate sequences.
Sakurai M; Sugano M; Handa H; Komai T; Yagi R; Nishigaki T; Yabe Y
Chem Pharm Bull (Tokyo); 1993 Aug; 41(8):1369-77. PubMed ID: 8403085
[TBL] [Abstract][Full Text] [Related]
39. Comparative pepstatin inhibition studies on individual human pepsins and pepsinogens 1,3 and 5(gastricsin) and pig pepsin A.
Roberts NB; Taylor WH
J Enzyme Inhib Med Chem; 2003 Jun; 18(3):209-17. PubMed ID: 14506911
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of inhibition of pepsin by pepstatin. Effect of inhibitor structure on dissociation constant and time-dependent inhibition.
Rich DH; Sun ET
Biochem Pharmacol; 1980 Aug; 29(16):2205-12. PubMed ID: 6775634
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
